Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Accenture
Colorcon
Chubb
US Army
Daiichi Sankyo
Deloitte
Merck
McKesson

Generated: December 14, 2018

DrugPatentWatch Database Preview

TRACRIUM PRESERVATIVE FREE Drug Profile

« Back to Dashboard

When do Tracrium Preservative Free patents expire, and when can generic versions of Tracrium Preservative Free launch?

Tracrium Preservative Free is a drug marketed by Hospira and is included in one NDA.

The generic ingredient in TRACRIUM PRESERVATIVE FREE is atracurium besylate. There are sixteen drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the atracurium besylate profile page.

Summary for TRACRIUM PRESERVATIVE FREE
Drug patent expirations by year for TRACRIUM PRESERVATIVE FREE
Medical Subject Heading (MeSH) Categories for TRACRIUM PRESERVATIVE FREE
Synonyms for TRACRIUM PRESERVATIVE FREE
2-(2-Carboxyethyl)-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-veratrylisoquinolinium benzenesulfonate, pentamethylene ester
2-(2-CARBOXYETHYL)-1,2,3,4-TETRAHYDRO-6,7-DIMETHOXY-2-METHYL-1-VERATRYLISOQUINOLINIUM BENZENESULFONATE,PENTAMETHYLENE ESTER
2,2'-((pentane-1,5-diylbis(oxy))bis(3-oxopropane-3,1-diyl))bis(1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium) benzenesulfonate
2,2'-[1,5-Pentanediylbis[oxy(3-oxo-3,1-propanediyl)]]bis[1-(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methylisoquinolinium] Dibenzenesulfonate
2,2'-[1,5-pentanediylbis[oxy(3-oxo-3,1-propanediyl)]]bis[1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-Isoquinolinium, dibenzenesulfonate (9CI); Atracurium besilate; Atracurium besylate; Atracurium
2,2'-[1,5-PENTANEDIYLBIS[OXY(3-OXO-3,1-PROPANEDIYL)]]BIS[1-[(3,4-DIMETHOXYPHENYL)METHYL]]-1,2,3,4-TETRAHYDRO-6,7-DIMETHOXY-2-METHYL-ISOQUINOLINIUM, BENZENESULFONATE (1:2)
2,2'-[1,5-PENTANEDIYLBIS[OXY(3-OXO-3,1-PROPANEDIYL)]]BIS[1-[3,4-DIMETHOXYPHENYL)METHYL]-1,2,3,4-TETRAHYDRO-6,7-DIMETHOXY-2-METHYLISO
2,2'-{pentane-1,5-diylbis[oxy(3-oxopropane-3,1-diyl)]}bis[1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolinium] bisbenzenesulfonate
2,2'-{pentane-1,5-diylbis[oxy(3-oxopropane-3,1-diyl)]}bis[1-{[3,4-bis(methyloxy)phenyl]methyl}-2-methyl-6,7-bis(methyloxy)-1,2,3,4-tetrahydroisoquinolinium] bisbenzenesulfonate
33 A 74
40AX66P76P
64228-79-1 (Parent)
64228-81-5
A834680
AB07163
AB1004899
AC1L2HUI
AKOS015895831
Ambap64228-79-1
AN-15362
AN-6664
AS-14131
Atracurii besilas
Atracurii besilas [INN-Latin]
Atracurium (besylate)
Atracurium besilate
Atracurium besilate (INN)
Atracurium besilate [INN]
Atracurium besylate
Atracurium besylate (USP)
Atracurium besylate [USAN:BAN]
Atracurium besylate [USAN:USP]
Atracurium Besylate Preservative Free
Atracurium besylate, >=98% (HPLC), powder
Atracurium besylate, European Pharmacopoeia (EP) Reference Standard
Atracurium besylate, mixture of isomers
Atracurium besylate, United States Pharmacopeia (USP) Reference Standard
atracurium dibenzenesulfonate
Atracurium for impurity F identification, European Pharmacopoeia (EP) Reference Standard
Atracurium for peak identification, European Pharmacopoeia (EP) Reference Standard
benzenesulfonate; 3-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoic acid 5-[3-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-
benzenesulfonate; 5-[3-[(1R,2R)-1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoyloxy]pentyl 3-[(1S,2S)-1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H
benzenesulfonate; 5-[3-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoyloxy]pentyl 3-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-i
benzenesulfonate;5-[3-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoyloxy]pentyl 3-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-di
Besilate d'atracurium
Besilate d'atracurium [INN-French]
Besilato de atracurio
Besilato de atracurio [INN-Spanish]
BW 33 A
BW 33A
BW-33A
BW-33A BESYLATE
C53H72N2O12
C65H82N2O18S2
CA0147
CAS-64228-81-5
CCG-213566
CHEBI:2915
CHEMBL1200527
Cisatracuriumbesylate
CS-2306
D00758
DB00732
DSSTox_CID_2630
DSSTox_GSID_22630
DSSTox_RID_76665
DTXSID6022630
EINECS 264-743-4
FT-0659516
HMS1568A11
HMS2095A11
HMS3651C21
HY-B0292A
hydro-1H-isoquinolin-2-ium-2-yl]propanoate
I06-1457
I14-0811
Isoquinolinium, 2,2'-(1,5-pentanediylbis(oxy(3-oxo-3,1-propanediyl)))bis(1-((3,4-dimethoxyphenyl)methyl)-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-, dibenzenesulfonate
ISOQUINOLINIUM,2,2'-[1,5-PENTANEDIYLBIS[OXY(3-OXO-3,1-PROPANEDIYL)]]BIS[1-(3,4-DIMETHOXYPHENYL)METHYL]-1,2,3,4-TETRAHYDRO-6,7-DIMETHOXY-2-METHYL-,DIBENZENESULFONATE
K027
KS-00000L5H
LETROZOLEX
LP101934
LS-176358
MolPort-003-940-284
NC00429
NCGC00017127-01
NCGC00262598-01
NCGC00262598-02
NSC-760047
NSC760047
Pentamethylen bis(3-(1,2,3,4-tetrahydro-6,7-dimethoxy-1-(3,4-dimethoxybenzyl)-2-methyl-2-isochinolyl)propionat) bis(benzolsulfonat)
PENTAMETHYLENE BIS(3-(1,2,3,4-TETRAHYDRO-6,7-DIMETHOXY-1-(3,4-DIMETHOXYBENZYL)-2-METHYL-2-ISOCHINOLYL)PROPIONATE)BIS(BENZOLSULFONATE)
Pharmakon1600-01505872
PubChem3018
Q-101018
Q-200864
SCHEMBL41251
SR-01000781272
SR-01000781272-3
TL8004537
Tox21_110790
Tracrium
Tracrium (TN)
TRACRIUM BESYLATE
UNII-40AX66P76P
XXZSQOVSEBAPGS-UHFFFAOYSA-L

US Patents and Regulatory Information for TRACRIUM PRESERVATIVE FREE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira TRACRIUM PRESERVATIVE FREE atracurium besylate INJECTABLE;INJECTION 018831-001 Nov 23, 1983 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Fuji
Harvard Business School
Medtronic
Julphar
Boehringer Ingelheim
Citi
Moodys
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.